Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
JAMA
    April 2024
  1. HARRIS E
    Study Examines Intermittent Fasting and Cardiovascular Mortality.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5158.
    >> Share

  2. WU F, Jacobs DR Jr, Daniels SR, Kahonen M, et al
    Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4819.
    >> Share

    March 2024
  3. HARRIS E
    Plastic in Arteries Tied With Higher Risk of Cardiovascular Problems.
    JAMA. 2024 Mar 29. doi: 10.1001/jama.2024.3707.
    >> Share

  4. YEH RW, Shlofmitz R, Moses J, Bachinsky W, et al
    Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.
    JAMA. 2024;331:1015-1024.
    >> Share

  5. KUNDU A, Moliterno DJ
    Drug-Coated Balloons for In-Stent Restenosis-Finally Leaving Nothing Behind for US Patients.
    JAMA. 2024;331:1011-1012.
    >> Share

  6. HARRIS E
    Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2091.
    >> Share

  7. XU J
    Sintilimab and Cardiovascular Toxicity-Reply.
    JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0676.
    >> Share

  8. PENG L, Yang D, Weng C
    Sintilimab and Cardiovascular Toxicity.
    JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0673.
    >> Share

  9. CHEN G, Shang M, Yang Y
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction-Reply.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0617.
    >> Share

  10. ZAKIEV V, Gvozdeva A, Skotnikov A
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0620.
    >> Share

  11. ASHAM H, Entezari-Maleki T
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0623.
    >> Share

  12. HARRIS E
    Blood Test Predicted Risk of Future Heart Attacks.
    JAMA. 2024;331:908.
    >> Share

  13. ANDERER S
    Cannabis Use Linked to Elevated Myocardial Infarction and Stroke Risk.
    JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2075.
    >> Share

  14. KO D, Pascual-Leone A, Shah SJ
    Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of Uncertainty.
    JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2991.
    >> Share

  15. HARRIS E
    High Niacin Levels May Raise Cardiovascular Disease Risk.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1566.
    >> Share

    January 2024
  16. BELL KJL, Glasziou PP, Doust JA
    Gestational Diabetes and Cardiovascular Health.
    JAMA. 2024;331:167.
    >> Share

  17. VENKATESH KK, Khan SS, Powe CE
    Gestational Diabetes and Cardiovascular Health-Reply.
    JAMA. 2024;331:167-168.
    >> Share

    December 2023
  18. LARKIN H
    What to Know About PREVENT, the AHA's New Cardiovascular Disease Risk Calculator.
    JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25115.
    >> Share

  19. HARRIS E
    Long-Term ADHD Medications and Cardiovascular Disease Risk.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.24173.
    >> Share

    November 2023
  20. HARRIS E
    Semaglutide Improved Cardiovascular Health in People Without Diabetes.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23508.
    >> Share

  21. KHAN SS, Grobman WA, Cameron NA
    Cardiovascular Health in the Postpartum Period.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.19192.
    >> Share

  22. LARKIN H
    Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.22276.
    >> Share

  23. GOLDSTEIN MR, Mascitelli L
    Bempedoic Acid for Primary Prevention of Cardiovascular Events.
    JAMA. 2023;330:1696.
    >> Share

  24. NISSEN SE, Nicholls SJ, Lincoff AM
    Bempedoic Acid for Primary Prevention of Cardiovascular Events-Reply.
    JAMA. 2023;330:1696-1697.
    >> Share

    October 2023
  25. CURFMAN G
    Traditional Chinese Medicine for ST-Segment Elevation Myocardial Infarction.
    JAMA. 2023;330:1546.
    >> Share

  26. YANG Y, Li X, Chen G, Xian Y, et al
    Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.
    JAMA. 2023;330:1534-1545.
    >> Share

  27. BACH RG
    Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart.
    JAMA. 2023;330:1529-1530.
    >> Share

  28. TAJEU GS, Joynt Maddox K, Brewer LC
    Million Hearts Cardiovascular Disease Risk Reduction Model.
    JAMA. 2023;330:1430-1432.
    >> Share

  29. JURASCHEK SP, Hu JR, Cluett JL, Ishak AM, et al
    Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
    JAMA. 2023;330:1459-1471.
    >> Share

  30. BLUE L, Kranker K, Markovitz AR, Powell RE, et al
    Effects of the Million Hearts Model on Myocardial Infarctions, Strokes, and Medicare Spending: A Randomized Clinical Trial.
    JAMA. 2023;330:1437-1447.
    >> Share

  31. SANCHEZ-DE-LA-TORRE M, Gracia-Lavedan E, Benitez ID, Sanchez-de-la-Torre A, et al
    Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis.
    JAMA. 2023;330:1255-1265.
    >> Share

    September 2023
  32. KAZI DS, Wadhera RK, Rome BN
    The Inflation Reduction Act and Access to High-Cost Cardiovascular Therapies.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.19129.
    >> Share

  33. HARRIS E
    Semaglutide Improves Heart Failure and Cardiovascular Disease.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16674.
    >> Share

    August 2023
  34. HSU NC, Fu YC, Hsu CH
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes.
    JAMA. 2023;330:771.
    >> Share

  35. PAGIDIPATI NJ, Granger CB, Nelson A
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes-Reply.
    JAMA. 2023;330:771-772.
    >> Share

  36. YOO SGK, Chung GS, Bahendeka SK, Sibai AM, et al
    Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries.
    JAMA. 2023;330:715-724.
    >> Share

  37. HELGASON H, Eiriksdottir T, Ulfarsson MO, Choudhary A, et al
    Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
    JAMA. 2023;330:725-735.
    >> Share

  38. HARRIS E
    How Sleep Apnea Contributes to Cardiovascular Disease.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.13939.
    >> Share

  39. KAWADA T
    Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin.
    JAMA. 2023;330:470-471.
    >> Share

  40. HONG SJ, Lee YJ, Hong MK
    Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin-Reply.
    JAMA. 2023;330:471.
    >> Share

    July 2023
  41. GOLDENBERG E
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults.
    JAMA. 2023;330:379.
    >> Share

  42. AGGARWAL R, Wadhera RK
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults-Reply.
    JAMA. 2023;330:379-380.
    >> Share

  43. CAMERON NA, Yee LM, Dolan BM, O'Brien MJ, et al
    Trends in Cardiovascular Health Counseling Among Postpartum Individuals.
    JAMA. 2023;330:359-367.
    >> Share

  44. KHURSHID S, Al-Alusi MA, Churchill TW, Guseh JS, et al
    Accelerometer-Derived "Weekend Warrior" Physical Activity and Incident Cardiovascular Disease.
    JAMA. 2023;330:247-252.
    >> Share

  45. AGGARWAL R, Chiu N, Libby P, Boden WE, et al
    Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020.
    JAMA. 2023;330:80-82.
    >> Share

  46. GELLERT GA, Jaszczak J
    Cardiovascular Disease Prevention Recommendations From an Online Chat-Based AI Model.
    JAMA. 2023;330:82-83.
    >> Share

  47. SARRAJU A, Rodriguez F, Laffin L
    Cardiovascular Disease Prevention Recommendations From an Online Chat-Based AI Model-Reply.
    JAMA. 2023;330:83.
    >> Share

    June 2023
  48. HARRIS E
    Testosterone Therapy Did Not Increase Major Cardiovascular Events.
    JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11959.
    >> Share

  49. KAZI DS
    Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease: Not a Statin Substitute but a Good Plan B.
    JAMA. 2023 Jun 24. doi: 10.1001/jama.2023.9854.
    >> Share

  50. NISSEN SE, Menon V, Nicholls SJ, Brennan D, et al
    Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.
    JAMA. 2023 Jun 24. doi: 10.1001/jama.2023.9696.
    >> Share

  51. HARRIS E
    Sex Differences in Post-Heart Attack Rehospitalizations.
    JAMA. 2023;329:1817-1818.
    >> Share

    May 2023
  52. KHAN SS, Post WS, Guo X, Tan J, et al
    Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events.
    JAMA. 2023;329:1768-1777.
    >> Share

    April 2023
  53. ROEHM E
    Medicare Advantage vs Traditional Medicare and 30-Day Mortality in Patients With AMI.
    JAMA. 2023;329:1121.
    >> Share

  54. LANDON BE, Curto V, Ayanian JZ
    Medicare Advantage vs Traditional Medicare and 30-Day Mortality in Patients With AMI-Reply.
    JAMA. 2023;329:1121-1122.
    >> Share

  55. LANDON BE, Hatfield LA, Bakx P, Banerjee A, et al
    Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries.
    JAMA. 2023;329:1088-1097.
    >> Share

    March 2023
  56. HONG SJ, Lee YJ, Lee SJ, Hong BK, et al
    Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
    JAMA. 2023 Mar 6:e232487. doi: 10.1001/jama.2023.2487.
    >> Share

  57. PAGIDIPATI NJ, Nelson AJ, Kaltenbach LA, Leyva M, et al
    Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Mar 6:e232854. doi: 10.1001/jama.2023.2854.
    >> Share

  58. AGGARWAL R, Yeh RW, Joynt Maddox KE, Wadhera RK, et al
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020.
    JAMA. 2023 Mar 5:e232307. doi: 10.1001/jama.2023.2307.
    >> Share

  59. ALLEN N, Wilkins JT
    The Urgent Need to Refocus Cardiovascular Disease Prevention Efforts on Young Adults.
    JAMA. 2023 Mar 5. doi: 10.1001/jama.2023.2308.
    >> Share

  60. RUDER K
    Large Study Finds Women Are (Still) Much More Likely to Die or Have Complications After Coronary Artery Bypass Graft Surgery Than Men.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.1806.
    >> Share

    February 2023
  61. CHU WM, Wang CY, Wei JC
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2023;329:426.
    >> Share

  62. HUH K, Kim YE, Jung J
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection-Reply.
    JAMA. 2023;329:426-427.
    >> Share

  63. SEDERHOLM LAWESSON S, Swahn E, Pihlsgard M, Andersson T, et al
    Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography.
    JAMA. 2023;329:393-404.
    >> Share

  64. SARRAJU A, Bruemmer D, Van Iterson E, Cho L, et al
    Appropriateness of Cardiovascular Disease Prevention Recommendations Obtained From a Popular Online Chat-Based Artificial Intelligence Model.
    JAMA. 2023 Feb 3. doi: 10.1001/jama.2023.1044.
    >> Share

    January 2023
  65. HARRIS E
    Changes in p53 Gene May Influence Cardiovascular Disease Risk.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0387.
    >> Share

  66. FONSECA AC
    Gout Flare and Cardiovascular Events.
    JAMA. 2023;329:96.
    >> Share

  67. CIPOLLETTA E, Tata LJ, Abhishek A
    Gout Flare and Cardiovascular Events-Reply.
    JAMA. 2023;329:96-97.
    >> Share

    December 2022
  68. DORRILL RA, Ashcraft A, Taitsman J
    Trends in Adverse Event Rates Among Hospitalized Patients From 2010 to 2019.
    JAMA. 2022;328:2271-2272.
    >> Share

  69. ELDRIDGE N, Metersky M, Grace E
    Trends in Adverse Event Rates Among Hospitalized Patients From 2010 to 2019-Reply.
    JAMA. 2022;328:2272-2273.
    >> Share

  70. ZENG BY, Tseng PT, Liang CS
    Dual Antiplatelet Therapy With Ticagrelor and Vein Graft Failure After Coronary Artery Bypass Graft Surgery.
    JAMA. 2022;328:2273.
    >> Share

  71. SANDNER S, Redfors B, Gaudino M
    Dual Antiplatelet Therapy With Ticagrelor and Vein Graft Failure After Coronary Artery Bypass Graft Surgery-Reply.
    JAMA. 2022;328:2273-2274.
    >> Share

  72. SURAN M
    Cardiovascular Corner-Researchers Probe Factors That May Contribute to Cardiovascular Health Disparities.
    JAMA. 2022 Dec 7. doi: 10.1001/jama.2022.22283.
    >> Share

  73. LANDON BE, Anderson TS, Curto VE, Cram P, et al
    Association of Medicare Advantage vs Traditional Medicare With 30-Day Mortality Among Patients With Acute Myocardial Infarction.
    JAMA. 2022;328:2126-2135.
    >> Share

    November 2022
  74. PAL N, Kertai MD, Butterworth J
    Fluid Bolus Administration and Cardiovascular Collapse in Critically Ill Patients Undergoing Tracheal Intubation.
    JAMA. 2022;328:2070-2071.
    >> Share

  75. TEJPAL A, Parotto M, Sklar MC
    Fluid Bolus Administration and Cardiovascular Collapse in Critically Ill Patients Undergoing Tracheal Intubation.
    JAMA. 2022;328:2069-2070.
    >> Share

  76. VAN DER VEN WH, Vlaar APJ, Veelo DP
    Fluid Bolus Administration and Cardiovascular Collapse in Critically Ill Patients Undergoing Tracheal Intubation.
    JAMA. 2022;328:2070.
    >> Share

  77. RUSSELL DW, Casey JD, Semler MW
    Fluid Bolus Administration and Cardiovascular Collapse in Critically Ill Patients Undergoing Tracheal Intubation-Reply.
    JAMA. 2022;328:2071-2072.
    >> Share

  78. OSERAN AS, Yeh RW
    Time to Treatment in ST-Segment Elevation Myocardial Infarction: Identifying Dangerous Delays or Diminishing Returns?
    JAMA. 2022 Nov 6. pii: 2798441. doi: 10.1001/jama.2022.19441.
    >> Share

  79. JOLLIS JG, Granger CB, Zegre-Hemsey JK, Henry TD, et al
    Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021.
    JAMA. 2022 Nov 6. pii: 2798440. doi: 10.1001/jama.2022.20149.
    >> Share

    October 2022
  80. SPENCE JD, Hankey GJ
    USPSTF Recommendations on Vitamin and Mineral Supplements for Primary Prevention of Cardiovascular Disease and Cancer.
    JAMA. 2022;328:1562-1563.
    >> Share

  81. MANGIONE C, Barry M, Wong J
    USPSTF Recommendations on Vitamin and Mineral Supplements for Primary Prevention of Cardiovascular Disease and Cancer-Reply.
    JAMA. 2022;328:1563-1564.
    >> Share

  82. KE C, Lipscombe LL, Weisman A, Zhou L, et al
    Trends in the Association Between Diabetes and Cardiovascular Events, 1994-2019.
    JAMA. 2022 Oct 14. pii: 2797494. doi: 10.1001/jama.2022.14914.
    >> Share

    September 2022
  83. HUDSON JA, Majonga ED, Ferrand RA, Perel P, et al
    Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.
    JAMA. 2022;328:951-962.
    >> Share

  84. FEINSTEIN MJ
    HIV, Subclinical Cardiovascular Disease, and Clinical Progression: Insights From Immunologic Heterogeneity.
    JAMA. 2022;328:931-932.
    >> Share

  85. CALDERON AT, Sanz-Sanchez J, Garcia-Garcia HM
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction.
    JAMA. 2022;328:891.
    >> Share

  86. BENSON VM
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction.
    JAMA. 2022;328:890-891.
    >> Share

  87. RABER L, Koskinas KC
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction-Reply.
    JAMA. 2022;328:891-892.
    >> Share

  88. SLOMSKI A
    Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes.
    JAMA. 2022;328:817.
    >> Share

  89. JAMES MT, Har BJ, Tyrrell BD, Faris PD, et al
    Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial.
    JAMA. 2022;328:839-849.
    >> Share

    August 2022
  90. CHOU R, Cantor A, Dana T, Wagner J, et al
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;328:754-771.
    >> Share

  91. JIN J
    Statins for the Prevention of Cardiovascular Disease.
    JAMA. 2022;328:786.
    >> Share

  92. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:746-753.
    >> Share

  93. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    >> Share

  94. SARKAR U, Bibbins-Domingo K
    Achieving Diagnostic Equity in Cardiovascular Disease.
    JAMA. 2022 Aug 15. pii: 2795499. doi: 10.1001/jama.2022.14424.
    >> Share

  95. LI L, Scott CA, Rothwell PM
    Association of Younger vs Older Ages With Changes in Incidence of Stroke and Other Vascular Events, 2002-2018.
    JAMA. 2022;328:563-574.
    >> Share

  96. RAO SV, Ohman EM
    Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery.
    JAMA. 2022;328:532-533.
    >> Share

  97. WUNNAVA S, Miller TA, Narang C, Nathan M, et al
    US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021.
    JAMA. 2022;328:580-582.
    >> Share

  98. SANDNER S, Redfors B, Angiolillo DJ, Audisio K, et al
    Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    JAMA. 2022;328:554-562.
    >> Share

  99. ANDERSON JL, Knowlton KU
    Cardiovascular Events and Gout Flares.
    JAMA. 2022;328:425-426.
    >> Share

  100. CIPOLLETTA E, Tata LJ, Nakafero G, Avery AJ, et al
    Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.
    JAMA. 2022;328:440-450.
    >> Share

    July 2022
  101. PATNODE CD, Redmond N, Iacocca MO, Henninger M, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive
    JAMA. 2022;328:375-388.
    >> Share

  102. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:367-374.
    >> Share

  103. SHUFELT CL, Mora S, Manson JE
    Aspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.
    JAMA. 2022 Jul 25. pii: 2794800. doi: 10.1001/jama.2022.11951.
    >> Share

  104. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
    >> Share

  105. LINDLEY KJ, Teal SB
    Contraception in Women With Cardiovascular Disease.
    JAMA. 2022 Jul 22. pii: 2794754. doi: 10.1001/jama.2022.11541.
    >> Share

  106. ABBASI J
    MASALA Study Probes Why People With South Asian Ancestry Have Increased Cardiovascular Disease Risks.
    JAMA. 2022 Jul 13. pii: 2794433. doi: 10.1001/jama.2022.11417.
    >> Share

  107. ELDRIDGE N, Wang Y, Metersky M, Eckenrode S, et al
    Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019.
    JAMA. 2022;328:173-183.
    >> Share

  108. SLOMSKI A
    High HDL Cholesterol Linked With Death in Coronary Artery Disease.
    JAMA. 2022;328:10.
    >> Share

    June 2022
  109. JIN J
    Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer.
    JAMA. 2022;327:2364.
    >> Share

  110. O'CONNOR EA, Evans CV, Ivlev I, Rushkin MC, et al
    Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;327:2334-2347.
    >> Share

  111. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;327:2326-2333.
    >> Share

  112. RUSSELL DW, Casey JD, Gibbs KW, Ghamande S, et al
    Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial.
    JAMA. 2022 Jun 16. pii: 2793545. doi: 10.1001/jama.2022.9792.
    >> Share

    May 2022
  113. UEMURA T
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
    JAMA. 2022;327:1928.
    >> Share

  114. PAPPALARDO F, Montisci A
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
    JAMA. 2022;327:1927-1928.
    >> Share

  115. LEVY B, Combes A, Girerd N
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO-Reply.
    JAMA. 2022;327:1928-1929.
    >> Share

    April 2022
  116. DAVIDSON KW, Barry MJ, Mangione CM, Cabana M, et al
    Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;327:1577-1584.
    >> Share

  117. BRETT AS
    Should Patients Take Aspirin for Primary Cardiovascular Prevention?: Updated Recommendations From the US Preventive Services Task Force.
    JAMA. 2022;327:1552-1554.
    >> Share

  118. JIN J
    Use of Aspirin to Prevent Cardiovascular Disease.
    JAMA. 2022;327:1624.
    >> Share

  119. GUIRGUIS-BLAKE JM, Evans CV, Perdue LA, Bean SI, et al
    Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;327:1585-1597.
    >> Share

  120. DEHMER SP, O'Keefe LR, Evans CV, Guirguis-Blake JM, et al
    Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
    JAMA. 2022;327:1598-1607.
    >> Share

  121. ABBASI J
    Highlights From the American College of Cardiology's Scientific Sessions-New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy.
    JAMA. 2022 Apr 20. pii: 2791572. doi: 10.1001/jama.2022.5487.
    >> Share

  122. RABER L, Ueki Y, Otsuka T, Losdat S, et al
    Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
    JAMA. 2022 Apr 3. pii: 2790913. doi: 10.1001/jama.2022.5218.
    >> Share

    March 2022
  123. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    >> Share

  124. LIN YH
    Mental Stress-Induced Myocardial Ischemia and Cardiovascular Events in Patients With Coronary Heart Disease.
    JAMA. 2022;327:1091.
    >> Share

  125. VACCARINO V, Bremner JD, Quyyumi AA
    Mental Stress-Induced Myocardial Ischemia and Cardiovascular Events in Patients With Coronary Heart Disease-Reply.
    JAMA. 2022;327:1091-1092.
    >> Share

  126. ABBASI J
    The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
    JAMA. 2022 Mar 2. pii: 2789793. doi: 10.1001/jama.2022.2411.
    >> Share

  127. DALZELL JR
    Review of Cardiogenic Shock After Acute Myocardial Infarction.
    JAMA. 2022;327:878.
    >> Share

  128. SAMSKY MD, Rao SV
    Review of Cardiogenic Shock After Acute Myocardial Infarction-Reply.
    JAMA. 2022;327:879.
    >> Share

    February 2022
  129. BHATT DL, Lopes RD, Harrington RA
    Diagnosis and Treatment of Acute Coronary Syndromes: A Review.
    JAMA. 2022;327:662-675.
    >> Share

  130. LEVY B, Girerd N, Amour J, Besnier E, et al
    Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial.
    JAMA. 2022;327:442-453.
    >> Share

    January 2022
  131. ABBASI J
    Highlights From the American Heart Association's Scientific Sessions-ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, and Aspirin and Dementia.
    JAMA. 2022;327:310-312.
    >> Share

    December 2021
  132. SLOMSKI A
    Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk.
    JAMA. 2021;326:2464.
    >> Share

  133. GREENE SJ, Butler J, Fonarow GC
    Contextualizing Risk Among Patients With Heart Failure.
    JAMA. 2021;326:2261-2262.
    >> Share

  134. RAY KK, Wright RS
    Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    JAMA. 2021;326:2205.
    >> Share

  135. WILKINS JT, Lloyd-Jones DM
    Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk-Reply.
    JAMA. 2021;326:2205-2206.
    >> Share

    November 2021
  136. NACHTIGALL M, Nachtigall RH
    The Role of Lipoprotein(a) in Cardiovascular Diseases.
    JAMA. 2021;326:2078.
    >> Share

  137. NATARAJAN P, Miksenas H, Januzzi JL Jr
    The Role of Lipoprotein(a) in Cardiovascular Diseases-Reply.
    JAMA. 2021;326:2078-2079.
    >> Share

  138. SLOMSKI A
    Intensive Blood Pressure Control Lowers Cardiovascular Risk.
    JAMA. 2021;326:2001.
    >> Share

  139. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    >> Share

  140. AMINIAN A, Al-Kurd A, Wilson R, Bena J, et al
    Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    JAMA. 2021 Nov 11. pii: 2786270. doi: 10.1001/jama.2021.19569.
    >> Share

  141. VACCARINO V, Almuwaqqat Z, Kim JH, Hammadah M, et al
    Association of Mental Stress-Induced Myocardial Ischemia With Cardiovascular Events in Patients With Coronary Heart Disease.
    JAMA. 2021;326:1818-1828.
    >> Share

  142. SAMSKY MD, Morrow DA, Proudfoot AG, Hochman JS, et al
    Cardiogenic Shock After Acute Myocardial Infarction: A Review.
    JAMA. 2021;326:1840-1850.
    >> Share

  143. BRAVO PE, Cappola TP
    Mental Stress-Induced Myocardial Ischemia: When the Mind Controls the Fate of the Heart.
    JAMA. 2021;326:1803-1804.
    >> Share

    October 2021
  144. SAAD M, Kennedy KF, Imran H, Louis DW, et al
    Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.
    JAMA. 2021 Oct 29. pii: 2785893. doi: 10.1001/jama.2021.18890.
    >> Share

  145. FANAROFF AC, Garcia S, Giri J
    Myocardial Infarction During the COVID-19 Pandemic.
    JAMA. 2021 Oct 29. pii: 2785894. doi: 10.1001/jama.2021.19608.
    >> Share

  146. HE J, Zhu Z, Bundy JD, Dorans KS, et al
    Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018.
    JAMA. 2021;326:1286-1298.
    >> Share

    September 2021
  147. ZUIN M, Rigatelli G, Zuliani G
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults.
    JAMA. 2021;326:1212-1213.
    >> Share

  148. WHITLOCK EL, Glymour MM
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults-Reply.
    JAMA. 2021;326:1213.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016